Understanding Cannabis and Acute Coronary Syndrome: A Mechanistic Review
This review consolidates evidence on cannabis acute coronary syndrome mechanisms, highlighting myocardial infarction risk and cardiovascular toxicology. It details sympathetic activation and coronary vasospasm as key pathways. Clinicians gain insights…
Clinical Evidence for Tirzepatide in Heart Risk Reduction
Tirzepatide cardiovascular mortality reduction is supported by clinical evidence demonstrating a 62% decrease in death risk among post-PCI patients. This dual incretin receptor agonist offers cardioprotective benefits beyond glucose control. These…
Young Man’s Heart Attack Linked to Cannabis Use — But One Case Can’t Prove Causation
This cannabis-induced Wellens syndrome case report details a young man's heart attack linked to cannabis use. The report highlights the complexity of attributing causation due to tobacco co-use and other risk factors. It underscores the need for further…